Myosin II and Rho kinase activity are required for melanosome aggregation in fish retinal pigment epithelial cells.
In the retinal pigment epithelium (RPE) of fish, melanosomes (pigment granules) migrate long distances through the cell body into apical projections in the light, and aggregate back into the cell body in the dark. RPE cells can be isolated from the eye, dissociated, and cultured as single cells in vitro. Treatment of isolated RPE cells with cAMP or the phosphatase inhibitor, okadaic acid (OA), stimulates melanosome aggregation, while cAMP or OA washout in the presence of dopamine triggers dispersion. Previous studies have shown that actin filaments are both necessary and sufficient for aggregation and dispersion of melanosomes within apical projections of isolated RPE. The role of myosin II in melanosome motility was investigated using the myosin II inhibitor, blebbistatin, and a specific rho kinase (ROCK) inhibitor, H-1152. Blebbistatin and H-1152 partially blocked melanosome aggregation triggered by cAMP in dissociated, isolated RPE cells and isolated sheets of RPE. In contrast, neither drug affected melanosome dispersion. In cells exposed to either blebbistatin or H-1152, then triggered to aggregate using OA, melanosome aggregation was completely inhibited. These results demonstrate that (1) melanosome aggregation and dispersion occur through different, actin-dependent mechanisms; (2) myosin II and ROCK activity are required for full melanosome aggregation, but not dispersion; (3) partial aggregation that occurred despite myosin II or ROCK inhibition suggests a second component of aggregation that is dependent on cAMP signaling, but independent of ROCK and myosin II.
Department of Biology, Saint Joseph's University, Philadelphia, Pennsylvania 19131, USA.
I B
IB
Barsoum
C
C
King-Smith
D000199:Actins / Q000378:metabolism / Q000502:physiology; D000818:Animals; D002449:Cell Aggregation / Q000502:physiology; D002465:Cell Movement / Q000502:physiology; D005399:Fishes; D006576:Heterocyclic Compounds, 4 or More Rings / Q000037:antagonists & inhibitors / Q000378:metabolism; D020460:Melanosomes / Q000378:metabolism / Q000502:physiology* / Q000648:ultrastructure; D018715:Microscopy, Video / Q000379:methods; D008870:Microtubules / Q000502:physiology; D024462:Myosin Type II / Q000378:metabolism* / Q000502:physiology; D019319:Okadaic Acid / Q000037:antagonists & inhibitors / Q000378:metabolism; D010857:Pigment Epithelium of Eye / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D012160:Retina / Q000166:cytology; D054460:rho-Associated Kinases / Q000378:metabolism*
D000199:Actins; D006576:Heterocyclic Compounds, 4 or More Rings; D019319:Okadaic Acid; C472645:blebbistatin; D054460:rho-Associated Kinases; D024462:Myosin Type II